Sirona Biochem to Exhibit at the Shanghai China Beauty Expo 2018

Vancouver, British Columbia – April 30, 2018 – Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (the “Company”) announced today that they will be exhibitors at China Beauty Expo (CBE) 2018. The trade show will be held May 22-24 in Shanghai, a growing hub in the cosmetic space.

The China Beauty Expo is the lead international beauty trade fair, providing a platform for key professionals in the cosmetic industry to meet and collaborate to enter the Asian market. Asia is currently the biggest market for beauty personal care ingredients and China specifically is the second biggest cosmetic market, with continued double-digit growth. The company looks forward to meeting with professionals from over 30 countries and discussing partnering opportunities.

As a member of the Cosmetic Valley, the company will also benefit from press and advertisement campaigns before, during and after the show. All exhibitors from the Cosmetic Valley will be part of the media promotional campaign for China Beauty Expo, along with featured pages in all show material including the May edition of Cosmetic News, which is sent out to 100,000 industry professionals in China. Sirona Biochem would like to extend their gratitude to the Normandy District and the Normandy Development Agency for sponsoring the trip.

While Sirona continues in its negotiations with a lead global partner alongside advanced due diligence from other partners, Sirona Biochem aims to expand its corporate presence in the Asian market. The company believes that its platform technology and pipeline will be of great interest to the CBE attendees, especially within the expanding Asian market.

“Ultimately, management’s responsibility is to bring as many players to the table to create a competitive environment on a licensing deal for 1067 and will continue such efforts until a definitive agreement is concluded,” said CEO, Dr. Howard Verrico.

With the extensive family of skin-lighteners within Sirona’s portfolio and novel LIP-01 anti-wrinkle compound, Sirona Biochem is well-positioned to meet the needs of the Asian consumers.

About China Beauty Expo

In its 23rd year, this show attracts a variety of beauty professionals, including importers, distributors, retailers and even beauty salons. Exhibitors are categorized by cosmetech, cosmetics and professional beauty.

In 2017, there were over 400,000 attendees from around the globe, including China, Korea, and the USA. This year, an anticipated 500,000 visitors will attend, alongside the 3,500 exhibitor booths. More specifically, there will be 1000 international brands from over 34 countries. Sirona Biochem will be one of the exhibitors within the Cosmetic Valley section.

For more information, visit: https://www.chinabeautyexpo.com/en/homepage.html

About Sirona Biochem Corp.

Sirona Biochem is a cosmetic ingredient and drug discovery company with a proprietary platform technology. Sirona specializes in stabilizing carbohydrate molecules with the goal of improving efficacy and safety. New compounds are patented for maximum revenue potential.

Sirona’s compounds are licensed to leading companies around the world in return for licensing fees, milestone fees and ongoing royalty payments. Sirona’s laboratory, TFChem, is located in France and is the recipient of multiple French national scientific awards and European Union and French government grants. For more information, please visit www.sironabiochem.com.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For more information regarding this press release, please contact:

Christopher Hopton, CFO
Sirona Biochem Corp.
Phone:  1.604.282.6064
Email: chopton@sironabiochem.com

———————————————

Sirona Biochem cautions you that statements included in this press release that are not a description of historical facts may be forward-looking statements. Forward-looking statements are only predictions based upon current expectations and involve known and unknown risks and uncertainties. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of release of the relevant information, unless explicitly stated otherwise.  Actual results, performance or achievement could differ materially from those expressed in, or implied by, Sirona Biochem’s forward-looking statements due to the risks and uncertainties inherent in Sirona Biochem’s business including, without limitation, statements about: the progress and timing of its clinical trials; difficulties or delays in development, testing, obtaining regulatory approval, producing and marketing its products; unexpected adverse side effects or inadequate therapeutic efficacy of its products that could delay or prevent product development or commercialization; the scope and validity of patent protection for its products; competition from other pharmaceutical or biotechnology companies; and its ability to obtain additional financing to support its operations. Sirona Biochem does not assume any obligation to update any forward-looking statements except as required by law.

 

Product Development

While carbohydrate-based molecules offer immense commercial potential, we are focusing on three programs at this time.